91 related articles for article (PubMed ID: 16126373)
1. Clotiapine compared with chlorpromazine in chronic schizophrenia.
Geller V; Gorzaltsan I; Shleifer T; Belmaker RH; Bersudsky Y
Schizophr Res; 2005 Dec; 80(2-3):343-7. PubMed ID: 16126373
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
Howanitz E; Pardo M; Smelson DA; Engelhart C; Eisenstein N; Stern RG; Losonczy MF
J Clin Psychiatry; 1999 Jan; 60(1):41-4. PubMed ID: 10074877
[TBL] [Abstract][Full Text] [Related]
3. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients.
Van Wyk AJ; Marais GF
S Afr Med J; 1971 Aug; 45(34):945-7. PubMed ID: 4939661
[No Abstract] [Full Text] [Related]
6. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
Stryjer R; Strous R; Bar F; Shaked G; Shiloh R; Rozencwaig S; Grupper D; Buchman N; Kotler M; Rabey JM; Weizman A
Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
[TBL] [Abstract][Full Text] [Related]
7. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
8. The risks and benefits of clozapine versus chlorpromazine.
Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
10. Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Hamner MB; Arvanitis LA; Miller BG; Link CG; Hong WW
Psychopharmacol Bull; 1996; 32(1):107-10. PubMed ID: 8927658
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Loebel A; Cucchiaro J; Sarma K; Xu L; Hsu C; Kalali AH; Pikalov A; Potkin SG
Schizophr Res; 2013 Apr; 145(1-3):101-9. PubMed ID: 23415311
[TBL] [Abstract][Full Text] [Related]
14. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Timdahl K; Carlsson A; Stening G
Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuroleptic treatments on peripheral opioid secretion.
Brambilla F; Facchinetti F; Petraglia F; Smeraldi E; Bellodi L; Brancato V; Genazzani AR
Neuropsychobiology; 1987; 18(2):68-73. PubMed ID: 2897644
[TBL] [Abstract][Full Text] [Related]
17. [Clotiapine in the treatment of acutely agitated patients: hardly any evidence].
Claeys J; Bervoets C; De Fruyt J
Tijdschr Psychiatr; 2017; 59(3):175-180. PubMed ID: 28350145
[TBL] [Abstract][Full Text] [Related]
18. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
Gelenberg AJ; Doller JC
J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.
Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ
Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472
[TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
